ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hematological and neurological expressed 1 (HN1) activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-Myc in hepatocellular carcinoma

Feng, Jutao*; Liu, Yanmin; Fang, Tianling; Zhu, Jinrong; Wang, Guoying; Li, Jun*广东药学院; 广州医学院; 1
CELL BIOLOGY INTERNATIONAL2023-3DOI: 10.1002/cbin.11957
3被引10阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) has a poor prognosis due to the usually advanced stage at diagnosis. Sustained activation of the MYC oncogene is implicated in the development of HCC; however, the molecular mechanisms of MYC deregulation in HCC are poorly understood. Here, real-time PCR and western blotting were used to measure the expression of hematological and neurological expressed 1 (HN1) in HCC cells. Expression of HN1 and MYC in clinical specimens was analyzed using immunohistochemistry. The role of HN1 in HCC proliferation, migration, and invasion was explored in vitro and in vivo. MYC expression was measured using real-time PCR and western blotting. MYC transcriptional activity was assessed using a luciferase reporter system. Expression of MYC target genes was quantified using real-time PCR. Protein interaction between MYC and HN1 was assessed using co-immunoprecipitation and western blotting. We identified HN1 as a novel regulatory factor of the glycogen synthase kinase (GSK) 3 beta-MYC axis. HN1 expression is elevated in liver tumor tissues and cells, and significantly correlates with poor survival in HCC patients. Upregulation of HN1 promotes, and silencing of HN1 represses, the proliferation and metastasis of liver cancer cells in vitro and in vivo. Moreover, our results demonstrate that HN1 sustains stabilization and persistent activity of MYC via interaction with GSK3 beta in HCC. Importantly, the tumor-promoting effects of HN1 on HCC cells were attenuated by suppressing MYC. In conclusion, constitutive activation of MYC by HN1 promotes the progression of HCC; therefore, HN1 might be a novel therapeutic target for HCC.

学科与关键词

关键词
hepatocellular carcinomaHN1MYC
相关
加载中…
  • NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma
    Zhang, Ye-wei; Chen, Qian; Li, Bo; Li, Hai-Yang; Zhao, Xue-Ke; Xiao, Yan-yi; Liu, Shu*; Zuo, Shi*Frontiers in Cell and Developmental Biology, 2021, 9: 659680.被引 9
  • MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma
    Zhu, Jinrong; Wu, Yongqi; Yu, Yijian; Li, Yan; Shen, Jianfei*; Zhang, Rongxin*Cell Death & Disease, 2022, 13(8): 727.被引 9
  • LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
    Luo, Yue; Lin, Junhao; Zhang, Jiakang; Song, Zhenghui; Zheng, Dayong; Chen, Fengsheng; Zhuang, Xuefen; Li, Aimin*; Liu, Xinhui*Canadian Journal of Gastroenterology and Hepatology, 2021, 2021: 9990338.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
CELL BIOLOGY INTERNATIONAL
发表日期
2023-03
卷期
第 47 卷, 第 3 期
页码
560-572
DOI
10.1002/cbin.11957
语言
ENGLISH
成果收录
SCIE
资助标注
Featured Clinical Technique of Guangzhou [2019TS26]; Science and Technology department of Guangdong Provinc [2019A1515110740]

作者

  • F

    Feng, Jutao (通讯) (第一作者)

    1 · guangzhou med univ

  • L

    Liu, Yanmin

    1 · guangzhou med univ

查看全部 6 位作者收起作者
  • F

    Fang, Tianling

    1 · guangzhou med univ

  • Z

    Zhu, Jinrong

    guangdong pharmaceut univ

  • W

    Wang, Guoying

    1 · guangzhou med univ

  • L

    Li, Jun (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417